Remove Chemotherapy Remove Clinic Management Remove Webinar
article thumbnail

Reinventing Transplant Care: From Inpatient Tradition to Outpatient Innovation

Pharmacy Times

In an interview with Pharmacy Times , LeAnne Kennedy, PharmD, BCOP, CPP, FHOPA, oncology clinical manager at Atrium Health Wake Forest Baptist in Winston-Salem, North Carolina, highlights the extensive role of pharmacists in the Wake Outpatient Transplant program. Again, I think that'll be a hybrid.

article thumbnail

The evolution of durvalumab in NSCLC care

Hospital Pharmacy Europe

Durvalumab is ‘promising step forward’ The latest approval from the MHRA is based on positive data from the AEGEAN Phase III trial in rNSCLC , which showed that durvalumab-based treatment before and after surgery reduced the risk of recurrence, progression events or death by 32% versus neoadjuvant chemotherapy alone.